VCL-HB01
/ Fresh Tracks Therap
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
February 27, 2019
Safety and Efficacy Study of Herpes Simplex Virus Type 2 (HSV-2) Therapeutic DNA Vaccine
(clinicaltrials.gov)
- P2; N=261; Completed; Sponsor: Vical; Active, not recruiting ➔ Completed; Trial completion date: Jul 2018 ➔ Dec 2018
Clinical • Trial completion • Trial completion date
1 to 1
Of
1
Go to page
1